Artosi, F. et al. 2025. Tildrakizumab as a Potential Option for Early Psoriatic Arthritis in Patients with Metabolic Comorbidities and Psoriasis: a Case Series. Dermatology Practical & Conceptual. 15, 4 (Oct. 2025), 5570. DOI:https://doi.org/10.5826/dpc.1504a5570.